Suresh Veeramani

1.4k total citations
23 papers, 1.0k citations indexed

About

Suresh Veeramani is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Suresh Veeramani has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Oncology. Recurrent topics in Suresh Veeramani's work include Advanced biosensing and bioanalysis techniques (5 papers), Protein Tyrosine Phosphatases (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Suresh Veeramani is often cited by papers focused on Advanced biosensing and bioanalysis techniques (5 papers), Protein Tyrosine Phosphatases (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Suresh Veeramani collaborates with scholars based in United States, Taiwan and Argentina. Suresh Veeramani's co-authors include Ming‐Fong Lin, Ta‐Chun Yuan, George J. Weiner, Fen-Fen Lin, Laura M. Rogers, Siao‐Yi Wang, Tsukasa Igawa, Surinder K. Batra, Sue Blackwell and Dev Karan and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Oncogene.

In The Last Decade

Suresh Veeramani

23 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suresh Veeramani United States 15 521 314 272 254 211 23 1.0k
Justine Y. Bruce United States 16 413 0.8× 275 0.9× 107 0.4× 329 1.3× 129 0.6× 73 955
Grant Wickman Canada 13 764 1.5× 291 0.9× 188 0.7× 374 1.5× 92 0.4× 21 1.4k
Tsuyoshi Takahashi Japan 16 426 0.8× 142 0.5× 340 1.3× 421 1.7× 107 0.5× 34 1.1k
Rajkumar Ganesan United States 22 618 1.2× 81 0.3× 400 1.5× 321 1.3× 219 1.0× 37 1.3k
Ismaël Hervé Koumakpayi Canada 15 801 1.5× 347 1.1× 102 0.4× 301 1.2× 76 0.4× 24 1.2k
Brian Higgins United States 14 1.2k 2.3× 436 1.4× 138 0.5× 444 1.7× 114 0.5× 26 1.6k
Patrick Maier Germany 16 417 0.8× 140 0.4× 111 0.4× 263 1.0× 139 0.7× 31 889
Phuong L. Doan United States 21 624 1.2× 136 0.4× 288 1.1× 258 1.0× 160 0.8× 57 1.4k
Yun Hee Kang South Korea 18 535 1.0× 115 0.4× 258 0.9× 332 1.3× 75 0.4× 44 1.0k
Douglas Halverson United States 14 720 1.4× 256 0.8× 208 0.8× 531 2.1× 65 0.3× 18 1.2k

Countries citing papers authored by Suresh Veeramani

Since Specialization
Citations

This map shows the geographic impact of Suresh Veeramani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh Veeramani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh Veeramani more than expected).

Fields of papers citing papers by Suresh Veeramani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh Veeramani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh Veeramani. The network helps show where Suresh Veeramani may publish in the future.

Co-authorship network of co-authors of Suresh Veeramani

This figure shows the co-authorship network connecting the top 25 collaborators of Suresh Veeramani. A scholar is included among the top collaborators of Suresh Veeramani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh Veeramani. Suresh Veeramani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veeramani, Suresh, et al.. (2024). AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamers. Molecular Therapy — Nucleic Acids. 35(4). 102358–102358. 4 indexed citations
2.
Lin, Li‐Hsien, et al.. (2023). Selection of a novel cell-internalizing RNA aptamer specific for CD22 antigen in B cell acute lymphoblastic leukemia. Molecular Therapy — Nucleic Acids. 33. 698–712. 4 indexed citations
3.
Narayan, Chandan, Suresh Veeramani, & William H. Thiel. (2021). Optimization of RNA Aptamer SELEX Methods: Improved Aptamer Transcript 3′-End Homogeneity, PAGE Purification Yield, and Target-Bound Aptamer RNA Recovery. Nucleic Acid Therapeutics. 32(1). 74–80. 12 indexed citations
4.
Ponnaiyan, Deepa, et al.. (2020). Evaluation of Endocan and Tumor Necrosis Factor-α as Inflammatory Biomarkers in Type 2 Diabetes and Periodontal Disease. Genetic Testing and Molecular Biomarkers. 24(7). 431–435. 11 indexed citations
5.
Veeramani, Suresh, Sue Blackwell, William H. Thiel, et al.. (2019). An RNA Aptamer–Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma Patients. Cancer Immunology Research. 7(9). 1511–1522. 6 indexed citations
6.
Veeramani, Suresh, Sue Blackwell, William H. Thiel, Paloma H. Giangrande, & George J. Weiner. (2016). Novel IL-2Ralpha (CD25)-Binding RNA Aptamer to Target T Regulatory Cells. Blood. 128(22). 3697–3697. 1 indexed citations
7.
Rogers, Laura M., Suresh Veeramani, & George J. Weiner. (2014). Complement in monoclonal antibody therapy of cancer. Immunologic Research. 59(1-3). 203–210. 81 indexed citations
8.
Veeramani, Suresh, Frank C. Lin, Sakthivel Muniyan, et al.. (2012). Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells. Free Radical Biology and Medicine. 53(1). 95–108. 26 indexed citations
9.
Veeramani, Suresh, Siao‐Yi Wang, Christopher E. Dahle, et al.. (2011). Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism. Blood. 118(12). 3347–3349. 96 indexed citations
10.
Lin, Fen-Fen, et al.. (2010). Human Prostatic Acid Phosphatase, an Authentic Tyrosine Phosphatase, Dephosphorylates ErbB-2 and Regulates Prostate Cancer Cell Growth. Journal of Biological Chemistry. 285(31). 23598–23606. 45 indexed citations
11.
Rajendran, Mythilypriya, Paul G. Thomes, Li Zhang, Suresh Veeramani, & Ming‐Fong Lin. (2010). p66Shc—a longevity redox protein in human prostate cancer progression and metastasis. Cancer and Metastasis Reviews. 29(1). 207–222. 42 indexed citations
12.
13.
Veeramani, Suresh, Ming‐Shyue Lee, & Ming‐Fong Lin. (2009). Revisiting histidine-dependent acid phosphatases: a distinct group of tyrosine phosphatases. Trends in Biochemical Sciences. 34(6). 273–278. 18 indexed citations
14.
Rajendran, Mythilypriya, et al.. (2008). A novel role of Shc adaptor proteins in steroid hormone-regulated cancers. Endocrine Related Cancer. 16(1). 1–16. 27 indexed citations
15.
Veeramani, Suresh, et al.. (2008). Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells. Oncogene. 27(37). 5057–5068. 61 indexed citations
16.
Yuan, Ta‐Chun, Suresh Veeramani, & Ming‐Fong Lin. (2007). Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocrine Related Cancer. 14(3). 531–547. 179 indexed citations
17.
Veeramani, Suresh, et al.. (2007). ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells. Oncogene. 26(54). 7552–7559. 23 indexed citations
18.
Yuan, Ta‐Chun, Suresh Veeramani, Fen-Fen Lin, et al.. (2006). Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells. Endocrine Related Cancer. 13(1). 151–167. 126 indexed citations
19.
Veeramani, Suresh, Ta‐Chun Yuan, Fen-Fen Lin, et al.. (2005). Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer. Endocrine Related Cancer. 12(4). 805–822. 78 indexed citations
20.
Veeramani, Suresh, Tsukasa Igawa, Ta‐Chun Yuan, et al.. (2005). Expression of p66Shc protein correlates with proliferation of human prostate cancer cells. Oncogene. 24(48). 7203–7212. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justine Y. Bruce Breakdown of academic impact, for papers by Grant Wickman Breakdown of academic impact, for papers by Tsuyoshi Takahashi Breakdown of academic impact, for papers by Rajkumar Ganesan Breakdown of academic impact, for papers by Ismaël Hervé Koumakpayi Breakdown of academic impact, for papers by Brian Higgins Breakdown of academic impact, for papers by Patrick Maier Breakdown of academic impact, for papers by Phuong L. Doan Breakdown of academic impact, for papers by Yun Hee Kang Breakdown of academic impact, for papers by Douglas Halverson
Rankless by CCL
2026